Fig. 5

Predictive power of six key lncRNAs for clinical progression of clear cell renal cell carcinoma (ccRCC) using receiver operating characteristic (ROC) curves. ROC curves were constructed to evaluate the predicted value of each key lncRNA for cancer progression including advanced tumor stages (T3–4), lymph node metastasis, metastasis, cancer status (with tumor), higher clinical stages (III–IV), and grade (G3–4). The x-axis shows the false positive rate, presented as “100%-Specificity,” while the y-axis indicates the true positive rate, shown as “Sensitivity.” *P < 0.05 for AUC of each lncRNA